• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Magnetic Dressing Improves Diabetic Wound Healing

      Magnetic Dressing Improves Diabetic Wound Healing

      Eko’s Newest CORE 500 Stethoscope: A Review

      Eko’s Newest CORE 500 Stethoscope: A Review

      Microfluidic System Incorporates Eight Organ Tissues for Drug Testing

      Microfluidic System Incorporates Eight Organ Tissues for Drug Testing

      Suction Cup Delivers Drugs Through Cheek

      Suction Cup Delivers Drugs Through Cheek

    • Radiology
      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

    • Cardiology
      Eko’s Newest CORE 500 Stethoscope: A Review

      Eko’s Newest CORE 500 Stethoscope: A Review

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

    • Surgery
      Magnetic Dressing Improves Diabetic Wound Healing

      Magnetic Dressing Improves Diabetic Wound Healing

      Sensor Monitors Transplanted Organs for Signs of Rejection

      Sensor Monitors Transplanted Organs for Signs of Rejection

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Stretchable E-Skin for Robotic Prostheses

      Stretchable E-Skin for Robotic Prostheses

      Glasses Provide Audible Prompts for Blind Wearers

      Glasses Provide Audible Prompts for Blind Wearers

      A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

      A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

      Robotic Ankle Helps with Postural Control in Amputees

      Robotic Ankle Helps with Postural Control in Amputees

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Fabry Disease Treatment Market Rising Size, Huge Business Growth Opportunities with COVID-19 Impact Analysis By 2031

September 21st, 2021 insightslice Releases

FABRY DISEASE appertains to a more extensive group of disorders called the lysosomal storage disorders. It is an x-linked condition induced by a modification in the GLA gene, which prompts to a lack of alpha galactosidase-A enzyme. Without this enzyme, large molecules like GL3 build-up cause progressively aggravating health issues. Fabry disease is additionally diagnosed if an atypical accumulation of a particular fatty matter globotriaosylceramide is noticed on the cellular level in the human body.

Symptoms include burning pain in the hands and feet, angiokeratomas, and decreased sweating. Manifestation of Fabry disease is the vascular disease, that is the cause of mortality and morbidity in a large number of the population globally.

Request a FREE Sample Copy at https://www.insightslice.com/request-sample/646

Acute need  for Fabry  Disease Treatment

Fabry disease causes accumulation of waste in the cells and improper disposition of cellular waste results in the cell being dead. Sooner or later, the entire organ malfunctions at first, and organ failure is the terminal outcome. If not treated in a timely manner, it may induce heart and kidney failure which proves to be fatal in most cases.

Promptly diagnosis through genetic testing is key to start the treatment at the initial cellular imbalance stage. Conferring to the studies without treatment, Fabry disease can bring upon complexities such as Kidney disease, Abnormal heart rhythms that is, Arrhythmias, heart enlargement, increased risk of strokes and seizures.

Fabry  Disease Treatment types

Two FDA-approved and over the years demonstrated treatments are implemented in the United States for Fabry disease treatment.

One is Enzyme replacement therapy with synthetic alpha-galactosidase A called AGALSIDEASE BETA. Second treatment is CHAPERONE THERAPY – MIGALASTAT which helps improve residual enzyme activity.

Besides these two therapies, treatment is fixated on Fabry-associated medical issues such as Medication for neuropathic pain, depression, and decreasing urine protein Levels.

Fabry disease is not a common health disorder, rather it is a rare disease.

Reported incidences are 1 out of 47,000 to 1/ 117000 in the general population.

Treatments like installing pacemakers to help with arrhythmias or renal transplant for renal failure are preferred post-diagnosis.

Request A Discount On The Report: https://www.insightslice.com/request-discount/646

Global  Fabry Disease Treatment Market driving factors

The preeminent driving factor for the Fabry disease treatment market is the recent approval of drugs used in the treatment of Fabry disease and its associated symptoms. Approval of novel drugs by various health care organizations resulted in revised treatment of a larger consumer base. Organizations like Food and Drug Administration(FDA) authorized a medication developed by Amicus Therapeutics, INC. Known as Galafold which is a Medication prescribed to adults, especially for oral consumption.

These administered mandates have been a major driving factor for the Fabry treatment market globally.

The enzyme replacement therapy segment held the largest market share in 2019 and is forecasted to continue holding major shares for the year 2020 – 2030. Increment in sales of Fabrazyme and Replagal medications adjacent to approval to probed and proven drugs are underpinning the growth of the enzyme replacement therapy segment.

Investment of local governments in health care systems has increased Fabry disease diagnosis in recent years. Due to the rise in cases diagnosed, prompting to the Expansion of the Fabery treatment market.

Besides government proactively implementing programs, market players are substantially investing in research, studies, and invention of effective medication. Research regarding novel therapies for the efficient treatment of Fabry disease are carried out globally. This is another major driving factor encouraging the global Fabry disease treatment market rise.

Due to the covid19 outbreak, patients are abstaining from getting treatments at health care centers and clinics. Home therapy is thought of as the most effective approach for enduring enzyme replacement therapy amidst covid19 outbreak as and when necessary.

Segments leading Global  Fabry Disease Treatment Market

Prodigious growth opportunities are foreseen for pharmaceutical companies based in the Asia Pacific in virtue of thriving healthcare investments besides the advancement of medical infrastructure in these regions. Based on geographical segment, during 2020 – 2030 pronto growth is expected potentially for the Asia Pacific region. Succeeded by Latin America, primarily due to large population in emerging countries.

Request For Customization: https://www.insightslice.com/request-customization/646

The key players of the Global Fabry Disease Treatment Market are Neuraltus Pharmaceutical, Inc, Novartis AG, Pfizer Inc., AVROBIO, Inc., Idorsia Pharmaceuticals Ltd, ISU Abxis Co Ltd, Greenovation Biotech GmbH, Amicus Therapeutics Inc., Shire Plc., Sanofi S.A., Moderna Therapeutics Inc., JCR Pharmaceuticals, Protalix Biotherapeutics Inc.

Global Fabry Disease Treatment Market Segmentations are :

By Product –

  • Enzyme Replacement Therapy (ERT)
  • Chaperone Treatment
  • Substrate Reduction Therapy (SRT)
  • Others

By Drugs-

  • Approved Drugs
    • Agalsidase Beta (Fabrazyme/Replagal)
    • Migalastat (Galafold)
  • Pipeline Drugs

By Molecule Type-

  • Small Molecule
  • Large Molecule (Biologics)

By Route of Administration-

  • Oral
  • Intravenous

By Distribution Channel-

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online pharmacies

By Region-

  • North America
    • United States
    • Canada
    • Rest of North America
  • South America
    • Brazil
    • Rest of South America
  • Europe
    • United Kingdom
    • Germany
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of APAC
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of MEA

Contact Info

422 Larkfield Ctr #1001,Santa Rosa,
California – 95403-1408, USA
info@insightslice.com
+1 (707) 736 6633

Sign up and submit a press release

Sponsored
Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation

Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation

PACKAGING COMPLIANCE LABS WELCOMES NEW CFO, BERNADETTE LEGARETTA

PACKAGING COMPLIANCE LABS WELCOMES JENN GOFF, VP SALES, MARKETING, AND INNOVATION

Clarius Debuts its First Dual-Array Wireless Handheld Scanner Enabling Whole-Body Views of Superficial to Deep Anatomy

Clarius Debuts its First Dual-Array Wireless Handheld Scanner Enabling Whole-Body Views of Superficial to Deep Anatomy

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

interviews & reviews
A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

Eko’s Newest CORE 500 Stethoscope: A Review

Eko’s Newest CORE 500 Stethoscope: A Review

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!